{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:52:38Z","timestamp":1785891158075,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018557","name":"Science and Technology Project of Nantong City","doi-asserted-by":"publisher","award":["JC2023108"],"award-info":[{"award-number":["JC2023108"]}],"id":[{"id":"10.13039\/501100018557","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["K2024011"],"award-info":[{"award-number":["K2024011"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["KYCX25_3805"],"award-info":[{"award-number":["KYCX25_3805"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["KYCX25_3796"],"award-info":[{"award-number":["KYCX25_3796"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cellsig.2026.112675","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:40:21Z","timestamp":1781278821000},"page":"112675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["AL109933.1 inhibits hepatocellular carcinoma progression via downregulating the Warburg effect and inactivating the YY1\/PKM2\/PIK3R1\/PI3K\/AKT\/ mTOR\/HIF-1\u03b1 axis"],"prefix":"10.1016","volume":"146","author":[{"given":"Yi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linling","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2026.112675_bb0005","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global epidemiology and genetics of hepatocellular carcinoma","volume":"164","author":"Ren","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cellsig.2026.112675_bb0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ijc.34040","article-title":"The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma","volume":"151","author":"Liao","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112675_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000339016","article-title":"Epidemiology and surveillance of hepatocellular carcinoma","volume":"1","author":"Kim","year":"2012","journal-title":"Liver Cancer"},{"key":"10.1016\/j.cellsig.2026.112675_bb0020","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","article-title":"Mechanisms of drug resistance in HCC","volume":"79","author":"Ladd","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.cellsig.2026.112675_bb0025","doi-asserted-by":"crossref","unstructured":"R. Donne, A. Lujambio, The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma, Hepatology 77 (2023) 1773\u20131796. https:\/\/ doi.org\/https:\/\/doi.org\/10.1002\/hep.32740.","DOI":"10.1002\/hep.32740"},{"key":"10.1016\/j.cellsig.2026.112675_bb0030","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80840","article-title":"eRNA profiling uncovers the enhancer landscape of oesophageal adenocarcinoma and reveals new deregulated pathways","volume":"12","author":"Ahmed","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.cellsig.2026.112675_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13202","article-title":"Enhancer RNA: what we know and what we can achieve","volume":"55","author":"Han","year":"2022","journal-title":"Cell Prolif."},{"key":"10.1016\/j.cellsig.2026.112675_bb0040","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/0008-5472.CAN-20-4010","article-title":"Implications of enhancer transcription and eRNAs in Cancer","volume":"81","author":"Adhikary","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112675_bb0045","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1038\/s41467-019-12543-5","article-title":"Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112675_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.657051","article-title":"Identification and validation of an immune-related eRNA prognostic signature for hepatocellular carcinoma","volume":"12","author":"Cai","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.cellsig.2026.112675_bb0055","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7150\/thno.78687","article-title":"Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m(6)A modification","volume":"13","author":"Zhao","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.cellsig.2026.112675_bb0060","article-title":"Identification of prognostic and immunotherapy-related eRNA ID2-AS1 in bladder cancer","volume":"101","author":"Zhang","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.cellsig.2026.112675_bb0065","article-title":"A novel and robust prognostic model for hepatocellular carcinoma based on enhancer RNAs-regulated genes","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2026.112675_bb0070","article-title":"Targeting of noncoding RNAs encoded by a novel MYC enhancers inhibits the proliferation of human hepatic carcinoma cells in vitro","volume":"12","author":"Choi","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2026.112675_bb0075","doi-asserted-by":"crossref","unstructured":"Ye M, Wang S, Qie JB, Sun PL. SPRY4-AS1, a novel enhancer RNA, is a potential novel prognostic biomarker and therapeutic target for hepatocellular carcinoma, Front. Oncol. 11 (2021) 765484. doi:https:\/\/doi.org\/10.3389\/fonc.2021. 765484.","DOI":"10.3389\/fonc.2021.765484"},{"key":"10.1016\/j.cellsig.2026.112675_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-024-02204-7","article-title":"Mir-483-5p-mediated activating of IGF2\/H19 enhancer up-regulates IGF2\/H19 expression via chromatin loops to promote the malignant progression of hepatocellular carcinoma","volume":"24","author":"Chen","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2026.112675_bb0085","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrc.2016.77","article-title":"Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?","volume":"16","author":"Hay","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2026.112675_bb0090","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cellsig.2026.112675_bb0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cellsig.2026.112675_bb0100","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","article-title":"The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression","volume":"95","author":"Vaupel","year":"2019","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.cellsig.2026.112675_bb0105","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41419-022-04632-z","article-title":"Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer","volume":"13","author":"Jiang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112675_bb0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.freeradbiomed.2019.08.007","article-title":"Pyruvate kinase M2: a simple molecule with complex functions","volume":"143","author":"Alquraishi","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cellsig.2026.112675_bb0115","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/cac2.12403","article-title":"METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression","volume":"43","author":"Xia","year":"2023","journal-title":"Cancer Commun."},{"key":"10.1016\/j.cellsig.2026.112675_bb0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13578-023-01089-1","article-title":"KITENIN promotes aerobic glycolysis through PKM2 induction by upregulating the c-Myc\/hnRNPs axis in colorectal cancer","volume":"13","author":"Varl\u0131","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.cellsig.2026.112675_bb0125","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41419-022-05361-z","article-title":"SOCS5 knockdown suppresses metastasis of hepatocellular carcinoma by ameliorating HIF-1\u03b1-dependent mitochondrial damage","volume":"13","author":"Luo","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112675_bb0130","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.3748\/wjg.v28.i32.4600","article-title":"Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1\u03b1-mediated glycolysis in hepatocellular carcinoma","volume":"28","author":"Zhou","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cellsig.2026.112675_bb0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.trecan.2019.02.009","article-title":"The opposing roles of PIK3R1\/p85\u03b1 and PIK3R2\/p85\u03b2 in cancer","volume":"5","author":"Vallejo-D\u00edaz","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cellsig.2026.112675_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612665","article-title":"The role of PIK3R1 in metabolic function and insulin sensitivity","volume":"24","author":"Tsay","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112675_bb0145","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1158\/1078-0432.CCR-21-4272","article-title":"The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer","volume":"28","author":"Chakraborty","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112675_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110943","article-title":"LncRNA CARMN suppresses EMT through inhibiting transcription of MMP2 activated by DHX9 in breast cancer","volume":"113","author":"Liao","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cellsig.2026.112675_bb0155","doi-asserted-by":"crossref","first-page":"110299","DOI":"10.1016\/j.mehy.2020.110299","article-title":"Mechanisms of insulin resistance, mitochondrial dysfunction and the action of the ketogenic diet in bipolar disorder. Focus on the PI3K\/AKT\/HIF1-a pathway","volume":"145","author":"Campbell","year":"2020","journal-title":"Med. Hypotheses."},{"key":"10.1016\/j.cellsig.2026.112675_bb0160","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1113\/JP285339","article-title":"Differential impact of sex on regulation of skeletal muscle mitochondrial function and protein homeostasis by hypoxia-inducible factor-1\u03b1 in normoxia","volume":"602","author":"Welch","year":"2024","journal-title":"J. Physiol."},{"key":"10.1016\/j.cellsig.2026.112675_bb0165","article-title":"Oxygen-independent expression of HIF-1\u03b1 during the cell cycle in hepatocellular carcinoma cells controls essential metabolic pathways under normoxia","author":"Gkotinakou","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.cellsig.2026.112675_bb0170","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/cas.12458","article-title":"Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1\u03b1\/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase\/Akt\/mammalian target protein of rapamycin pathway in multiple myeloma cells","volume":"105","author":"Wang","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cellsig.2026.112675_bb0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hep.24015","article-title":"P28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase\/AKT\/hypoxia-inducible factor-1\u03b1 pathways","volume":"53","author":"Fu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cellsig.2026.112675_bb0180","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s12253-019-00585-5","article-title":"Current status and perspective biomarkers in AFP negative HCC: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage","volume":"26","author":"Luo","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.cellsig.2026.112675_bb0185","doi-asserted-by":"crossref","unstructured":"C. Huang, H. Cui, X. Lang, F. Zhao, An integrative analysis revealing ZFHX4-AS1 as a novel prognostic biomarker correlated with immune infiltrates in ovarian cancer, J. Immunol. Res. (2022) 9912732. doi:https:\/\/doi.org\/10.1155\/2022\/9912732.","DOI":"10.1155\/2022\/9912732"},{"key":"10.1016\/j.cellsig.2026.112675_bb0190","doi-asserted-by":"crossref","first-page":"113754","DOI":"10.1016\/j.yexcr.2023.113754","article-title":"A mutator-derived prognostic eRNA signature provides insight into the pathogenesis of breast cancer","volume":"431","author":"Wang","year":"2023","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cellsig.2026.112675_bb0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.molcel.2014.08.023","article-title":"Enhancer RNA facilitates NELF release from immediate early genes","volume":"56","author":"Schaukowitch","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellsig.2026.112675_bb0200","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","article-title":"Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression","volume":"73","author":"Li","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cellsig.2026.112675_bb0205","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41574-020-0329-9","article-title":"Insulin-PI3K signalling: an evolutionarily insulated metabolic driver of cancer","volume":"16","author":"Hopkins","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cellsig.2026.112675_bb0210","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1128\/MCB.00440-07","article-title":"Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1","volume":"27","author":"Kim","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellsig.2026.112675_bb0215","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1038\/s41467-025-66168-y","article-title":"Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma","volume":"16","author":"Lu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112675_bb0220","first-page":"02071","article-title":"The HIF-1\u03b1\/LGR5\/MAPK axis enhances hypoxia-induced metastatic potential in LGR5-positive hepatocellular carcinoma","author":"Zhuo","year":"2026","journal-title":"Genes Dis."},{"key":"10.1016\/j.cellsig.2026.112675_bb0225","article-title":"Matrix stiffness-induced YEATS2 drives HCC progression via epigenetic activation of the TGFBR2-TAZ-AKT pathway","author":"Zhang","year":"2026","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellsig.2026.112675_bb0230","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41392-024-01963-5","article-title":"He p-MYH9\/USP22\/HIF-1\u03b1 axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma","volume":"9","author":"Shan","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2026.112675_bb0235","doi-asserted-by":"crossref","unstructured":"Yu M, Yang D, Chen X, Yang Y, Zhang B, Jiang X, Xing L, Yang Y, Sun Y, Li N, Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities, Mol. Biomed. doi:https:\/\/doi.org\/10.1186\/s43556-026-00427-2.","DOI":"10.1186\/s43556-026-00427-2"},{"key":"10.1016\/j.cellsig.2026.112675_bb0240","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/jcp.30536","article-title":"Multiple functions of pyruvate kinase M2 in various cell types","volume":"237","author":"Lee","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cellsig.2026.112675_bb0245","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/ncb3630","article-title":"PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis","volume":"19","author":"Liu","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cellsig.2026.112675_bb0250","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1158\/0008-5472.CAN-17-2109","article-title":"Metabolic determinants of sensitivity to phosphatidylinositol 3-kinase pathway inhibitor in small-cell lung carcinoma","volume":"78","author":"Makinoshima","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112675_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpb.2022.110734","article-title":"Insulin activates LC-PUFA biosynthesis of hepatocytes by regulating the PI3K\/Akt\/mTOR\/Srebp1 pathway in teleost Siganus canaliculatus","volume":"260","author":"Liu","year":"2022","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600330X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600330X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:27:24Z","timestamp":1785889644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682600330X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S089865682600330X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112675","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AL109933.1 inhibits hepatocellular carcinoma progression via downregulating the Warburg effect and inactivating the YY1\/PKM2\/PIK3R1\/PI3K\/AKT\/ mTOR\/HIF-1\u03b1 axis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112675"}}